Blog

Myasthenia Gravis

Myasthenia Gravis Stages: From Eye Muscle Weakness to Generalized Symptoms

Nurse explaining myasthenia gravis stages to patient

Myasthenia gravis (MG) is an autoimmune neuromuscular disorder that causes muscle weakness and rapid fatigue in the voluntary muscles (muscles we can move and control, such as the eye muscles). Myasthenia gravis has a sudden onset, and its symptoms may change and progress over time, affecting different body parts. 

Speak to a Specialist About Copay Assistance

(877) 778-0318

Based on the symptoms and the type of muscles affected, myasthenia gravis is classified into five stages — ranging from mild to severe. Since each stage responds differently to treatment, a thorough diagnosis is required for effective patient treatment outcomes. 

This article discusses the five stages (classes) of myasthenia gravis that can help you identify the condition and seek medical attention in time. 

The Five Stages of Myasthenia Gravis

Healthcare providers classify the stages of myasthenia gravis based on the symptoms and the extent of the weakness an individual is experiencing. 

Early Stage: Class I

In the early stage, MG affects your eye muscles — in particular, the ocular muscles that control the movement of your eyes. Therefore, your eyelids become slightly weaker. This initial stage is called ocular myasthenia gravis since muscle weakness is only limited to the eyes. 

During this stage, an individual may experience the following symptoms:

  • Ptosis (drooping of eyelids)
  • Diplopia (double vision) 
  • Trouble focusing

Around 85% of patients experience ptosis or diplopia as a first symptom of myasthenia gravis. These symptoms may fluctuate, such as becoming more pronounced with fatigue and improving with rest. 

Since MG is difficult to diagnose in its early stages, a doctor may misdiagnose your ailment, believing the symptoms to be related to eye problems. 

Mild Stage Myasthenia Gravis: Class II

MG may affect other muscle groups beyond the eyes during the first two years of onset. For instance, muscles that control facial expressions can become weaker, and as a result, people experience difficulty in smiling. However, the symptom’s severity remains relatively mild during this stage. 

Generalized Myasthenia Gravis: Class III – V

Nurse talking to patient

Ocular myasthenia gravis often progresses to generalized myasthenia gravis within a year of onset if not diagnosed and treated earlier. In generalized myasthenia gravis, muscle weakness spreads to other parts of your body, such as the head and neck. 

The muscles surrounding the head and neck are called bulbar muscles. They are involved in speaking, swallowing, chewing, and holding the jaw in place. 

Around 15% of patients experience bulbar muscle weakness as an initial symptom. Symptoms include:

  • Difficulty chewing or frequent choking
  • Dysphagia (difficulty swallowing)
  • Hoarseness (changes in pitch and quality of the voice)
  • Dysarthria (difficulty speaking)
  • Dropped-head syndrome

The severity of the symptoms remains relatively moderate during this stage. Furthermore, the classes III – V in generalized myasthenia gravis are further categorized based on the severity and extent of muscle involvement.

4. Myasthenia Gravis Stage: Class IV

In stage IV, muscle weakness in the upper limbs becomes more pronounced than in the lower limbs. Patients struggle to do everyday tasks such as gripping or lifting objects, climbing stairs, walking, and sitting up. 

Muscle weakness may reach maximum severity within one to three years of onset in most people. However, with proper treatment, people can remain physically active. 

Get Financial Assistance

Schedule a Consultation

 

5. Myasthenic Crisis: Class V

Class V is the severe stage of myasthenia gravis, also known as myasthenic crisis. In this stage, muscle weakness in the respiratory system causes difficulty breathing. The muscles that control breathing become severely weak and unable to perform properly.
This is a serious, life-threatening stage and requires immediate medical care, such as intubation or mechanical ventilation to maintain the airway. 
 

Conclusion

Myasthenia gravis (MG) is a long-term but rare neuromuscular disorder, causing muscle weakness in different parts of your body —  ranging from the eyes (ocular myasthenia gravis) to respiratory failure (severe stage). Understanding the stages of myasthenia gravis and the affected muscles can help you receive timely treatment. 

REFERENCES:

  1. Suresh, A. B., & Asuncion, R. M. D. (2023b). Myasthenia gravis. StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK559331/
  2. Myasthenia Gravis Clinical Overview | MGFA. https://myasthenia.org/Professionals/Clinical-Overview-of-MG
  3. Hehir, M. K., & Silvestri, N. J. (2018). Generalized myasthenia gravis. Neurologic Clinics, 36(2), 253–260. https://doi.org/10.1016/j.ncl.2018.01.002
  4. Professional, C. C. M. Myasthenia gravis (MG). Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/17252-myasthenia-gravis-mg
  5. Gilhus, N. E., & Verschuuren, J. J. (2015). Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurology, 14(10), 1023–1036. https://doi.org/10.1016/s1474-4422(15)00145-3
This information is not a substitute for medical advice or treatment. Talk to your doctor or healthcare provider about your medical condition prior to starting any new treatment. AmeriPharma™ Specialty Care assumes no liability whatsoever for the information provided or for any diagnosis or treatment made as a result, nor is it responsible for the reliability of the content. AmeriPharma™ Specialty Care does not operate all the websites/organizations listed here, nor is it responsible for the availability or reliability of their content. These listings do not imply or constitute an endorsement, sponsorship, or recommendation by AmeriPharma™ Specialty Care. This webpage may contain references to brand-name prescription drugs that are trademarks or registered trademarks of pharmaceutical manufacturers not affiliated with AmeriPharma™ Specialty Care.
Dr. Mark Alfonso
MEDICALLY REVIEWED BY Dr. Mark Alfonso, PharmD, BCMTMS

Dr. Mark Alfonso, PharmD was born and raised in Pueblo, CO. He received his pharmacy degree from the University of Colorado School of Pharmacy at the Anschutz Medical Campus in 2010. He was board certified in medication therapy management in 2022. The most rewarding part of his job is helping to answer patient questions and concerns. His areas of expertise are community pharmacy and medication therapy management.  In his free time, he enjoys reading and running.

Contact Us

Use the HIPAA-compliant form below to request a refill of your prescription. If you have any questions about your medication or how to administer it, please visit the Contact Us page or call us at (877) 778-0318.

By submitting, you agree to AmeriPharma’s Terms of Use, Privacy Policy, and Notice of Privacy Practices